Thomas J. Wickham
Impact in
Papers in
- Co-authors
- Glen R. Nemerow (7 shared papers)Imre Kovesdi (31 shared papers)David A. Cheresh (4 shared papers)Patricia Mathias (3 shared papers)Peter W. Roelvink (16 shared papers)Douglas E. Brough (4 shared papers)Alena Lizonová (4 shared papers)Jeffrey M. Bergelson (4 shared papers)
- Journals
- Journal of Virology (17 papers)Human Gene Therapy (7 papers)Gene Therapy (4 papers)Biotechnology Progress (3 papers)The Journal of Gene Medicine (3 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Thomas J. Wickham
80 papers receiving 9.3k citations
Thomas J. Wickham's Hit Papers
Peers
Comparison fields: 5 of 114
- Genetics 6.5k
- Oncology 3.0k
- Molecular Biology 5.9k
- Infectious Diseases 1.4k
- Biotechnology 505
Countries citing papers authored by Thomas J. Wickham
This map shows the geographic impact of Thomas J. Wickham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Wickham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Wickham more than expected).
Fields of papers citing papers by Thomas J. Wickham
This network shows the impact of papers produced by Thomas J. Wickham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Wickham. The network helps show where Thomas J. Wickham may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas J. Wickham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment Hit paper breakdown → | 1993 | 1935 |
| 2 | 1998 | 547 | |
| 3 | 1997 | 421 | |
| 4 | 1994 | 361 | |
| 5 | 1999 | 349 | |
| 6 | 2017 | 332 | |
| 7 | 1998 | 307 | |
| 8 | 1996 | 293 | |
| 9 | 1996 | 257 | |
| 10 | 1994 | 238 | |
| 11 | 1992 | 231 | |
| 12 | 1999 | 191 | |
| 13 | Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. | 1995 | 185 |
| 14 | 2001 | 184 | |
| 15 | 1997 | 182 | |
| 16 | 2000 | 154 | |
| 17 | 1993 | 146 | |
| 18 | 2016 | 141 | |
| 19 | Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. | 2001 | 123 |
| 20 | 2003 | 122 |
About Thomas J. Wickham
Thomas J. Wickham is a scholar working on Genetics, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 80 papers that have together received 9.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (53 papers), CAR-T cell therapy research (27 papers), Viral Infectious Diseases and Gene Expression in Insects (22 papers), RNA Interference and Gene Delivery (22 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Viral gastroenteritis research and epidemiology (11 papers), Viral Infections and Immunology Research (8 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Genetics (6.5k citations), Oncology (3.0k citations), Molecular Biology (5.9k citations), Infectious Diseases (1.4k citations) and Biotechnology (505 citations). Thomas J. Wickham has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Glen R. Nemerow, Imre Kovesdi, David A. Cheresh, Patricia Mathias, Peter W. Roelvink, Douglas E. Brough, Alena Lizonová, Jeffrey M. Bergelson, David A. Einfeld and Michael Louis Shuler. Their work appears in journals such as Journal of Virology, Human Gene Therapy, Gene Therapy, Biotechnology Progress and The Journal of Gene Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.